Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2205 of 6351
-
JAKAVI under the microscope: new study tracks GVHD treatment in real life
Disease control Recruiting nowThis study aims to evaluate the safety and effectiveness of Jakavi® (ruxolitinib) in patients with acute graft-versus host disease (GVHD) and chronic GVHD in clinical practice.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can four therapy sessions stop suicide reattempts? swedish study aims to find out
Knowledge-focused Recruiting nowThe goal of this study is to determine whether Brief Cognitive Behaviour Therapy (BCBT), a four-session psychological treatment aimed at reducing suicide attempts, is acceptable and feasible to deliver during psychiatric inpatient care for adults who have been hospitalised follow…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Robots take on knee surgery: a new trial for PCL fractures
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the efficacy of robotic-assisted surgery in the management of posterior cruciate ligament (PCL) avulsion fractures involving the tibial insertion site of the cruciate ligament. Specifically, the study seeks to determine:…
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Blood pressure breakthrough? device shows promise for High-Altitude hypertension
Disease control Not yet recruitingThis study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The study participants are adult patients with hypertension who have been long-term residents (for \>6 months) in high-altitude regions (≥2500 m). They are randomly assigned to o…
Phase 3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Which vaccine schedule works best? new study aims to protect babies from pneumococcal disease
Prevention Not yet recruitingTo compare the immunogenicity of the domestically produced PCV13 vaccine in healthy 2-month-old infants following administration via the 2+1 and 3+1 schedules, with the primary endpoint being the seroprevalence of specific IgG antibodies after completion of the vaccination series…
Sponsor: Beijing Center for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New oral painkiller aims to ease recovery after orthopedic surgery
Symptom relief Recruiting nowThis clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.
Phase 2/3 • Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New gel treatment for Parkinson's aims to reduce 'Off' time
Disease control Recruiting nowThe primary objective of the study is to assess the effectiveness of LECIGON® treatment on the reduction in OFF time (h/day) from baseline at 12 months as measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part IV (MDS-UPDRS IV).
Sponsor: Britannia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New injection could shrink nasal polyps without surgery
Disease control CancelledThis is a randomized, multicenter, double-blind, Phase 3 study with 2 parallel groups. The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2 different dosing regimens of itepekimab monotherapy in Japanese participants aged 18 years or older with chr…
Phase 3 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Sound wave device aims to crack hardened heart arteries
Disease control Recruiting nowA prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
Sponsor: Amplitude Vascular Systems, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Robot vs surgeon: which knee replacement works better?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the VELYS Robotic-Assisted Solution (VRAS) device helps to improve outcomes from total knee replacement, when compared to regular non-robotic-assisted total knee replacement in the treatment of osteoarthritis. It will also aim to rev…
Sponsor: Golden Jubilee National Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Experimental 'Off-the-Shelf' CAR-T therapy takes on tough lymphoma
Disease control Not yet recruitingThis single-arm, open-label pilot study will assess the safety and efficacy of RN1701, a bispecific CD19/CD20-targeted allogeneic CAR-T-cell product, in patients with relapsed or refractory B-cell lymphoma. Up to 19 participants will be enrolled in a conventional 3 + 3 dose-escal…
Early phase 1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo heart procedure aims to cut stroke risk and improve heart function in AF patients
Disease control By invitation onlyThis study is a prospective, multicenter, single-blinded, randomized controlled trial to investigate whether concomitant left atrial appendage closure (LAAC) and pulsed field ablation (PFA) is more effective than LAAC alone in improving the outcomes in persistent atrial fibrillat…
Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Online brain health course could slash dementia risk
Prevention Recruiting nowThis study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conve…
Sponsor: University of British Columbia • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Which training style best fixes leg strength imbalances?
Disease control CompletedThis randomized, parallel-group study evaluated the effects of an 8-week unilateral resistance training program with strength- and velocity-oriented loading on limb-specific load-velocity relationships and lower-limb asymmetry in male university team-sport players. Participants w…
Sponsor: South China Normal University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New vaccine trial targets Hard-to-Treat colorectal cancer liver metastases
Vaccine Recruiting nowThis study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with metastatic colorectal cancer.
Phase 1 • Sponsor: West China Hospital • Aim: Vaccine
Last updated Jul 31, 2026 00:00 UTC
-
AI app aims to speed up labor decisions for doctors and nurses
Knowledge-focused Recruiting nowPregnancy and childbirth are uniquely important events in women's lives because they are accompanied by major physical, emotional, and psychological changes. Maternal satisfaction, emotional well-being, and perceptions of childbirth are strongly influenced by the quality of labor…
Sponsor: Delta University for Science and Technology • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Which shoulder surgery works best for arthritis? mayo clinic launches trial
Symptom relief Recruiting nowThe purpose of this study is to determine if patients undergoing anatomic total shoulder arthroplasty (aTSA) will have improved patient reported outcome scores at 1 year compared to those undergoing reverse total shoulder arthroplasty (rTSA).
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Gut feeling: can a probiotic lift depression?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if Bifidobacterium PB-18 can treat mild to moderate depressive disorder in adults aged 18 to 65 years who are not taking antidepressants or other psychotropic medications during the study. It will also learn about the safety of Bifidoba…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New peptide serum takes on hair loss in head-to-head trial
Disease control Recruiting nowThis study aims to evaluate the effectiveness and tolerability of a peptide-based hair serum compared with topical minoxidil in patients with androgenetic alopecia. Participants will be randomly assigned, in a double-blind manner, to receive either the peptide hair serum or topic…
Sponsor: Institute of Dermatology, Thailand • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Magnetic pulses to the brain may ease autism symptoms
Symptom relief Recruiting nowExploring the therapeutic efficacy of Theta Burst Stimulation (TBS) over the right inferior frontal gyrus (RIFG) in autism, including changes in core symptoms, adaptive functioning, neuropsychological performance, and neurophysiological signals.
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC